HomeOnline ResultsCitrix LoginDownloadsDiagnosis CodesContact InfoSearch

CHC LABS INC.

SEDIMENTATION RATE, ERYTHROCYTE

(85651,85652)

200.20

Burkitt’s tumor or lymphoma, unspecified site, extranodal and solid organ sites

200.21

Burkitt’s tumor or lymphoma involving lymph nodes of head, face, and neck

200.22

Burkitt’s tumor or lymphoma involving intrathoracic lymph nodes

200.23

Burkitt’s tumor or lymphoma involving intra-abdominal lymph nodes

200.24

Burkitt’s tumor or lymphoma involving lymph nodes of axilla and upper limb

200.25

Burkitt’s tumor or lymphoma involving lymph nodes of inguinal region and lower limb

200.26

Burkitt’s tumor or lymphoma involving intrapelvic lymph nodes

200.27

Burkitt’s tumor or lymphoma involving spleen

200.28 Burkitt’s tumor or lymphoma involving lymph nodes of multiple sites

201.40

Hodgkin’s disease, lymphocytic-histiocytic predominance, unspecified site, extranodal and solid organ sites

201.41

Hodgkin’s disease, lymphocytic-histiocytic predominance involving lymph nodes of head, face, and neck

201.42

Hodgkin’s disease, lymphocytic-histiocytic predominance involving intrathoracic lymph nodes

201.43

Hodgkin’s disease, lymphocytic-histiocytic predominance involving intra abdominal lymph nodes

201.44

Hodgkin’s disease, lymphocytic-histiocytic predominance involving lymph nodes of axilla and upper limb

201.45

Hodgkin’s disease, lymphocytic-histiocytic predominance involving lymph nodes of inguinal region and lower limb

201.46

Hodgkin’s disease, lymphocytic-histiocytic predominance involving intrapelvic lymph nodes

201.47

Hodgkin’s disease, lymphocytic-histiocytic predominance involving spleen

201.48

Hodgkin’s disease, lymphocytic-histiocytic predominance involving lymph nodes, multiple sites

201.50

Hodgkin’s disease, nodular sclerosis, unspecified site, extranodal and solid organ sites

201.51

Hodgkin’s disease, nodular sclerosis, involving lymph nodes of head, face, and neck

201.52

Hodgkin’s disease, nodular sclerosis, involving intrathoracic lymph nodes

201.53

Hodgkin’s disease, nodular sclerosis, involving intra-abdominal lymph nodes

201.54

Hodgkin’s disease, nodular sclerosis, involving lymph nodes of axilla and upper limb

201.55

Hodgkin’s disease, nodular sclerosis, involving lymph nodes of inguinal region and lower limb

201.56

Hodgkin’s disease, nodular sclerosis, involving intrapelvic lymph nodes

201.57

Hodgkin’s disease, nodular sclerosis, involving spleen

201.58

Hodgkin’s disease, nodular sclerosis, involving lymph nodes of multiple sites

201.60

Hodgkin’s disease, mixed cellularity, unspecified site, extranodal and solid organ sites

 

201.61

Hodgkin’s disease, mixed cellularity, involving lymph nodes of head, face, and neck

201.62

Hodgkin’s disease, mixed cellularity, involving intrathoracic lymph nodes

201.63

Hodgkin’s disease, mixed cellularity, involving intra-abdominal lymph nodes

201.64

Hodgkin’s disease, mixed cellularity, involving lymph nodes of axilla and upper limb

201.65

Hodgkin’s disease, mixed cellularity, involving lymph nodes of inguinal region and lower limb

201.66

Hodgkin’s disease, mixed cellularity, involving intrapelvic lymph nodes

201.67

Hodgkin’s disease, mixed cellularity, involving spleen

201.68

Hodgkin’s disease, mixed cellularity, involving lymph nodes of multiple sites

201.70

Hodgkin’s disease, lymphocytic depletion, unspecified site, extranodal and solid organ sites

201.71

Hodgkin’s disease, lymphocytic depletion, involving lymph nodes of head, face, and neck

201.72

Hodgkin’s disease, lymphocytic depletion, involving intrathoracic lymph nodes

201.73

Hodgkin’s disease, lymphocytic depletion, involving intra-abdominal lymph nodes

201.74

Hodgkin’s disease, lymphocytic depletion, involving lymph nodes of axilla and upper limb

201.75

Hodgkin’s disease, lymphocytic depletion, involving lymph nodes of inguinal region and lower limb

201.76

Hodgkin’s disease, lymphocytic depletion, involving intrapelvic lymph nodes

201.77

Hodgkin’s disease, lymphocytic depletion, involving spleen

201.78

Hodgkin’s disease, lymphocytic depletion, involving lymph nodes of multiple sites

201.90

Hodgkin’s disease, unspecified type, unspecified site, extranodal and solid organ sites

201.91

Hodgkin’s disease, unspecified type, involving lymph nodes of head, face, and neck

201.92

Hodgkin’s disease, unspecified type, involving intrathoracic lymph nodes

201.93

Hodgkin’s disease, unspecified type, involving intra-abdominal lymph nodes

201.94

Hodgkin’s disease, unspecified type, involving lymph nodes of axilla and upper limb

201.95

Hodgkin’s disease, unspecified type, involving lymph nodes of inguinal region and lower limb

201.96

Hodgkin’s disease, unspecified type, involving intrapelvic lymph nodes

201.97

Hodgkin’s disease, unspecified type, involving spleen

201.98

Hodgkin’s disease, unspecified type, involving lymph nodes of multiple sites

202.00

Nodular lymphoma, unspecified site, extranodal and solid organ sites

202.01

Nodular lymphoma involving lymph nodes of head, face, and neck

202.02

Nodular lymphoma involving intrathoracic lymph nodes

202.03

Nodular lymphoma involving intra-abdominal lymph nodes

202.04

Nodular lymphoma involving lymph nodes of axilla and upper limb

202.05

Nodular lymphoma involving lymph nodes of inguinal region and lower limb

202.06

Nodular lymphoma involving intrapelvic lymph nodes

202.07

Nodular lymphoma involving spleen

202.08

Nodular lymphoma involving lymph nodes of multiple sites

 

202.80

Other malignant lymphomas, unspecified site, extranodal and solid organ sites

202.81

Other malignant lymphomas involving lymph nodes of head, face, and neck

202.82

Other malignant lymphomas involving intrathoracic lymph nodes

202.83

Other malignant lymphomas involving intra-abdominal lymph nodes

202.84

Other malignant lymphomas involving lymph nodes of axilla and upper limb

202.85

Other malignant lymphomas involving lymph nodes of inguinal region and lower limb

202.86

Other malignant lymphomas involving intrapelvic lymph nodes

202.87

Other malignant lymphomas involving spleen

202.88

Other malignant lymphomas involving lymph nodes of multiple sites

240.0-240.9

Simple and unspecified goiter

241.0-241.9

Nontoxic nodular goiter

242.00-242.91

Thyrotoxicosis with or without goiter

245.0-245.9

Thyroiditis

246.8

Other specified disorders of thyroid

279.4

Autoimmune disease, not elsewhere classified

362.34

Transient arterial occlusion

379.91

Pain in or around eye

391.0

Acute rheumatic pericarditis

391.1

Acute rheumatic endocarditis

391.2

Acute rheumatic myocarditis

391.8

Other acute rheumatic heart disease

410.00-410.02

Acute myocardial infarction of anterolateral wall

410.10-410.12

Acute myocardial infarction of other anterior wall

410.20-410.22

Acute myocardial infarction of inferolateral wall

410.30-410.32

Acute myocardial infarction of inferoposterior wall

410.40-410.42

Acute myocardial infarction of other inferior wall

410.50-410.52

Acute myocardial infarction of other later wall

410.60-410.62

True posterior wall infarction

410.70-410.72

Subendocardial infarction

446.0

Polyarteritis nodosa

446.5

Giant cell arteritis

447.6

Arteritis, unspecified

556.0-556.9

Ulcerative colitis

696.0

Psoriatic arthropathy

710.0

Systemic lupus erythematosus

710.1

Systemic sclerosis, use additional code to identify manifestation

710.2

Sicca syndrome

710.4

Polymyositis

710.9

Unspecified diffuse connective tissue disease

714.0

Rheumatoid arthritis

714.1

Felty’s syndrome

714.2

Other rheumatoid arthritis with visceral or systemic involvement

714.30

Polyarticular juvenile rheumatoid arthritis, chronic or unspecified

714.81

Rheumatoid lung

714.9

Unspecified inflammatory polyarthropathy

716.59

Unspecified polyarthropathy or polyarthritis, multiple sites

719.49

Pain in joint, multiple sites

720.0

Ankylosing spondylitis

725

Polymyalgia rheumatica

729.1

Myalgia and myositis, unspecified

733.99

Other disorders of bone and cartilage (e.g., relapsing polychondritis)

783.21

Loss of weight

 

784.0

Headache

E933.1

Drugs, medicinal and biological substances causing adverse effects in therapeutic use, antineoplastic and immunosuppressive drugs

E933.8

Drugs, medicinal and biological substances causing adverse effects in therapeutic use, other systemic agents, not elsewhere classified

E935.6

Drugs, medicinal and biological substances causing adverse effects in therapeutic use, antirheumatics (antiphlogistics)

E947.2

Drugs, medicinal and biological substances causing adverse effects in therapeutic use, antidotes and chelating agents, not elsewhere classified

V10.72

Personal history of Hodgkin’s disease

 


   This policy has been duplicated from the most current Medicare National Coverage Determination or Local Medical Review Policy available at the time this booklet was printed in October 2005. Medicare will consider this test(s) medically reasonable and necessary only if the test(s) was performed for any of the diagnoses/conditions listed on this page. This information is subject to change without notice, and Covenant Health Care Labs (CHC) is not responsible for consequences that may result from using such information. CHC is not indicating one code is more acceptable than another, and that selected codes should reflect the patients actual medical condition as noted in their medical record.

 

For questions or comments about this site, please contact  webmaster@chclabs.com
©2006 Covenant Health Care INC. All Rights Reserved